← back to search

Yasser Alatawi

University of Tabuk · SA
Area of research
Epidemiology · Geriatrics and Gerontology
Research interest
Research interests include Acute Ischemic Stroke Management, Pharmaceutical Practices and Patient Outcomes, COVID-19 and Mental Health, and Pharmacovigilance and Adverse Drug Reactions.
h-index
15
citations
845
works
59
NIH funding
primary concept
email

Recent publications

Smart wearable sensor-based model for monitoring medication adherence using sheep flock optimization algorithm-attention-based bidirectional long short-term memory (SFOA-Bi-LSTM)
Digital Health 2025cited by 4position: firstdoi
Sea Horse Optimization–Deep Neural Network: A Medication Adherence Monitoring System Based on Hand Gesture Recognition
Sensors 2024cited by 2position: middledoi
The impact of cognitive impairment on survival and medication adherence among older women with breast cancer
Breast Cancer 2020cited by 12position: firstdoi
The association between antidepressants use and development of cognitive impairment among older women diagnosed with breast cancer
European Geriatric Medicine 2020cited by 0position: firstdoi
Authors' Reply to Courtney Suggs and Colleagues’ Comment on: “Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs”
Drug Safety 2018cited by 1position: middledoi
Empirical estimation of under-reporting in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)
Expert Opinion on Drug Safety 2017cited by 193position: firstdoi
Comparison of brand versus generic antiepileptic drug adverse event reporting rates in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS)
Epilepsy Research 2017cited by 26position: middledoi
Methodological Considerations for Comparison of Brand Versus Generic Versus Authorized Generic Adverse Event Reports in the US Food and Drug Administration Adverse Event Reporting System (FAERS)
Clinical Drug Investigation 2017cited by 15position: middledoi
Mixed Approach Retrospective Analyses of Suicide and Suicidal Ideation for Brand Compared with Generic Central Nervous System Drugs
Drug Safety 2017cited by 13position: middledoi
Brand vs generic adverse event reporting patterns: An authorized generic-controlled evaluation of cardiovascular medications
Journal of Clinical Pharmacy and Therapeutics 2017cited by 13position: firstdoi
The association between health beliefs and medication adherence among patients with type 2 diabetes
Research in Social and Administrative Pharmacy 2015cited by 68position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Richard A. Hansen · Parsons (United States)8 papers (2017–2020)Ning Cheng · University of California, San Francisco5 papers (2017–2018) · 5 papers (2017–2018)Md. Mahfuzur Rahman · Khulna University5 papers (2017–2018) · 5 papers (2017–2018)C. David Page · Duke University3 papers (2017–2018)Vishnu Suppiramaniam · Kennesaw State University2 papers (2020–2020)Guanqun Cao · Michigan State University2 papers (2020–2020)Chiahung Chou · Takeda (United States)2 papers (2020–2020) · 2 papers (2024–2025) · 2 papers (2024–2025) · 2 papers (2024–2025) · 2 papers (2024–2025) · 2 papers (2024–2025)Ahmed Aljabri · University of Arizona2 papers (2024–2025) · 2 papers (2024–2025) · 2 papers (2024–2025)Muralikrishnan Dhanasekaran · Auburn University2 papers (2024–2025)Gladys Ekong · Western New England University1 papers (2015–2015)David Page · University of California System1 papers (2017–2017)